Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin.

Scherzer, TM; Stättermayer, AF; Strasser, M; Laferl, H; Maieron, A; Stauber, R; Datz, C; Dulic-Lakovic, E; Steindl-Munda, P; Hofer, H; Ferenci, P; HEPATOLOGY. 2011; 54(5): 1518-1526.

Infusion reactions to the chimeric EGFR inhibitor cetuximab-change to the fully human anti-EGFR monoclonal antibody panitumumab is safe

Resch, G; Schaberl-Moser, R; Kier, P; Kopetzky, G; Scheithauer, W; Sliwa, T; Greil, R; Nosslinger, T; Mayrbaurl, B; Thaler, J ANN ONCOL. 2011; 22(2): 486-U251.

Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.

Ofner, D; Devries, AF; Schaberl-Moser, R; Greil, R; Rabl, H; Tschmelitsch, J; Zitt, M; Kapp, KS; Fastner, G; Keil, F; Eisterer, W; Jäger, R; Offner, F; Gnant, M; Thaler, J; Strahlenther Onkol. 2011; 187(2): 100-107.

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis

Eichhorst, BF; Fischer, K; Fink, AM; Elter, T; Wendtner, CM; Goede, V; Bergmann, M; Stilgenbauer, S; Hopfinger, G; Ritgen, M; Bahlo, J; Busch, R; Hallek, M BLOOD. 2011; 117(6): 1817-1821.

Assessing protein immunogenicity with a dendritic cell line-derived endolysosomal degradome.

Egger, M; Jurets, A; Wallner, M; Briza, P; Ruzek, S; Hainzl, S; Pichler, U; Kitzmuller, C; Bohle, B; Huber, CG; Ferreira, F PLoS One. 2011; 6(2):e17278

Current evidence for the treatment of invasive fungal infections in immunocompromised patients

Auberger, J; Lass-Florl, C; Clinical investigation. 2011; 1 (3): 447-457.

Protein Kinase C-beta Dependent Activation of NF-kappa B in Stromal Cells Is Indispensable for the Survival of Chronic Lymphocytic Leukemia B-Cells in Vivo

Lutzny, G; Kocher, T; Rudelius, M; Schmidt-Supprian, M; Klein-Hitpass, L; Durig, J; Oostendorp, RAJ; Peschel, C; Egle, A; Ringshausen, I BLOOD. 2012; 120(21):

Abstract S4-3: The EndoPredict score identifies late distant metastases in ER+/HER2− breast cancer patients

Dubsky, P; Brase, JC; Fisch, K; Jakesz, R; Singer, CF; Greil, R; Dietze, O; Weber, KE; Petry, C; Kronenwett, R; Rudas, M; Knauer, M; Gnant, M; Filipits, M; Cancer Research. 2012; 72(24 Suppl.):-Thirty-Fifth Annual CTRC‐AACR San Antonio Breast Cancer Symposium; 04.-08.12.2012; San Antonio, TX.

T Cell Exhaustion Contributes to Immune Evasion in Chronic Lymphocytic Leukaemia

Gassner, FJ; Zaborsky, N; Neureiter, D; Huemer, M; Egle, A; Hartmann, TN; Greil, R; Geisberger, R BLOOD. 2012; 120(21):

CMV reactivation may protect against relapse in HLA-C KIR ligand group homozygous but not heterozygous recipients following allogeneic peripheral blood stem cell transplantation

Clausen, J; Kircher, B; Auberger, J; Schumacher, P; Grabmer, C; Muhlbacher, A; Gastl, G; Nachbaur, D BONE MARROW TRANSPL. 2012; 47: S275-S275.